Cellbox Solutions
PrivateLast Round
Series A
Mar 5, 2026
Est. Valuation
$29.17M
Total Funding Raised
$13.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellbox Solutions operates in Healthcare & Life Sciences and is based in Cologne. Its latest recorded funding round was a Series A round in March 2026.
Cellbox Solutions is a biotechnology company that develops portable CO₂ incubators for the safe, temperature- and CO₂-controlled transport of living cells and biological materials.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Pharma Supply Chain, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellbox Solutions Comparables
Compare Cellbox Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Micro Q Technologies | 77% | |
| Cryoport | 66% | |
| Azenta, Inc. | 64% |
For institutional investors. Book with your work email.
Cellbox Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 5, 2026 | ||||
| Grant | Jul 5, 2023 | ||||
| Series A Extension | Mar 7, 2023 | ||||
| Accelerator | Oct 24, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellbox Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| NRW.Venture | Series A Extension |
| CK Venture Capital | Series A Extension |
| Fraunhofer Ventures | Series A Extension |
| NRW.Bank | Series A |
| BioTools Innovator | Accelerator |
| BAB Beteiligungs- und Managementgesellschaft Bremen mbH | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 64, 305% of headcount.
- Jul 13, 2026
Open roles increased from 0 to 5, representing 24% of headcount.
For institutional investors. Book with your work email.
Cellbox Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellbox Solutions's valuation, stock price, and market status.
Is Cellbox Solutions a public or private company?
Cellbox Solutions is a private company.
What is the current stock price of Cellbox Solutions?
Cellbox Solutions is a private company, so its shares have no public market price. Caplight tracks Cellbox Solutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellbox Solutions worth (valuation)?
Cellbox Solutions's valuation is estimated at $29.2M based on funding round data.
Can I buy Cellbox Solutions stock?
Cellbox Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellbox Solutions's last funding round?
Cellbox Solutions's most recent funding round was Series A on March 5, 2026.
Who are the main investors in Cellbox Solutions?
Key investors in Cellbox Solutions include CK Venture Capital, Companisto.
Will Cellbox Solutions IPO soon?
No public IPO plans have been announced for Cellbox Solutions.
How can I track Cellbox Solutions secondary market activity?
Caplight tracks bids, offers, and trades in Cellbox Solutions's shares on secondary markets.